Atrial Fibrillation Incidence, Risk Factors and Genetics


Phase N/A Results N/A

Summary of Purpose

To assess the risk of incident atrial fibrillation after stopping anti-hypertensive medication including beta-blockers and ACE inhibitors. Also, to assess the role of genetics in subsequent risk of stroke among patients with atrial fibrillation.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 23 July 2008.

1 Jul 2002 10 Aug 2001 1 Jun 2008 1 Jun 2008 1 Jul 2008 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design



Not available